We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-27.36%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$713M
AUM Growth
-$364M
Cap. Flow
-$63.5M
Cap. Flow %
-8.91%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
SER icon
Serina Therapeutics
SER
+$10.8M

Top Sells

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$6.57M
2
MNST icon
Monster Beverage
MNST
+$5.13M
3
STAA icon
STAAR Surgical
STAA
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 55.12%
2 Consumer Staples 32.32%
3 Industrials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$343M 48.1%
10,740,630
-114,549
-1% -$4.46M
MNST icon
2
Monster Beverage
MNST
$94.3B
$230M 32.32%
9,358,616
-188,800
-2% -$5.13M
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$56.2M 7.89%
420,000
– –
AXON
4
Axon Enterprise
AXON
$42.5B
$33.3M 4.67%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$27.4M 3.84%
29,971,561
-4,285,933
-13% -$6.57M
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$10.4M 1.47%
378,247
– –
SER icon
7
Serina Therapeutics
SER
$30M
$8.96M 1.26%
+85,219
New +$10.8M
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$3.28M 0.46%
5,292,156
– –
DAL icon
9
PUT
Delta Air Lines
DAL
$57.5B
– –
-200,000
Closed -$11.6M
MNST icon
10
PUT
Monster Beverage
MNST
$94.3B
– –
-1,600,000
Closed -$46.6M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Broadwood Capital held 10 positions worth $713M, down 34% from $1.08B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $63.5M in Q4 2018, closing 2 positions and reducing 3 holdings. Its largest reduction was Lineage Cell Therapeutics, cutting an estimated $6.57M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 57% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Broadwood Capital opened a new position in Serina Therapeutics worth $8.96M.

  • Broadwood Capital's largest Q4 2018 buy was Serina Therapeutics: 85,219 shares worth $8.96M.
  • Broadwood Capital's biggest Q4 2018 reduction was Lineage Cell Therapeutics, cutting an estimated $6.57M.
  • Broadwood Capital's ten largest holdings make up 100% of its $713M portfolio in Q4 2018.
  • Broadwood Capital opened 1 new position and closed 2 in Q4 2018.
  • Broadwood Capital's portfolio value fell 34% quarter-over-quarter to $713M.

Based on Broadwood Capital's 13F filing for Q4 2018, filed 14 Feb 2019.